Microdosing Mushrooms: A Beginner's Guide To Safe Usage

Microdosing involves taking a fraction of a regular dose of a psychedelic substance, such as psilocybin mushrooms or LSD, to harness their physiological effects while minimizing unwanted side effects. A microdose is typically defined as 5-10% of a usual psychoactive dose, with an estimated range of 0.1 to 0.3 grams of dried magic mushrooms for psilocybin. Microdosing has gained popularity as a means to enhance mood, emotional well-being, and cognition, with some reporting reduced stress, depression, and anxiety. However, there is limited research on the effects of microdosing, and it may not be suitable for everyone. It is important to understand the legal landscape and potential risks before considering microdosing.

What is a microdose?

Microdosing is the practice of taking a fraction of a regular dose of a psychedelic substance. The most widely reported substances used for microdosing are psilocybin mushrooms and LSD, and to a lesser degree, other psychedelic substances such as mescaline and 2-CB.

A microdose is typically defined as 5-10% of a usual psychoactive dose, with an estimated range of 0.1 to 0.3 grams of dried magic mushrooms for psilocybin. However, due to the variability in the potency of mushrooms, these dose calculations are only estimates.

Microdosing is done at lower doses and on a non-daily schedule. People who microdose generally take these doses semi-regularly, about two to three days a week.

There are different ways to microdose mushrooms. The mushrooms can be chewed up dry or added to hot tea, broth, or soup. They can also be crushed or put in a coffee grinder and mixed with chocolate or put into gelatin capsules and taken orally.

Microdosing is not recommended for people with cardiac conditions, heart valve problems, a history of psychosis, or a family history of psychosis. Pregnant and lactating women should also avoid microdosing.

How to prepare a microdose

Microdosing involves taking a fraction of a regular dose of a psychedelic substance. The most commonly reported substances used for microdosing are psilocybin mushrooms and LSD, with psilocybin being the psychoactive molecule in magic mushrooms.

To prepare a microdose, it is important to first determine the correct dosage. A microdose is typically defined as 5-10% of a usual psychoactive dose, with an estimated range of 0.1 to 0.3 grams of dried magic mushrooms for psilocybin. However, it is important to note that the potency of mushrooms can vary, so it is recommended to start with a lower dose and increase gradually until the desired effects are achieved.

Once the correct dosage has been determined, there are several ways to prepare and consume the microdose:

• The mushrooms can be chewed dry.
• They can be added to hot tea, broth, or soup.
• They can be crushed or put in a coffee grinder and mixed with chocolate or gelatin capsules to be taken orally.
• Psilocybin mushrooms can also be combined with other substances such as lion's mane mushrooms (Hericium erinaceus; HE) and niacin (vitamin-B3) in a process known as "stacking". However, it is important to do your own research and consult with a healthcare professional or therapist knowledgeable about microdosing before combining substances.

It is also important to consider the legal status of psilocybin mushrooms in your region and to ensure that you understand and adhere to local laws and regulations. In some areas, cultivating psilocybin mushrooms for personal use may be permitted, allowing individuals to ensure a consistent, reliable, and safe supply.

How often to microdose

Microdosing involves taking a fraction of a regular dose of a psychedelic substance. The frequency of microdosing mushrooms varies, and people who microdose generally take these doses on a semi-regular basis—two to three days a week. However, the frequency can range from three to five times per week. It is important to note that microdosing is not recommended for daily use.

The frequency of microdosing mushrooms can depend on various factors, including the individual's goals, health status, and tolerance. It is crucial to consult a healthcare professional or therapist knowledgeable about microdosing practices to ensure a safe and effective experience.

When determining the frequency of microdosing mushrooms, it is essential to consider the potential risks and side effects. While microdosing is generally considered safer than taking a full dose of psychedelics, caution is still advised. Some research suggests that repeated microdosing of psilocybin can cause valvular heart disease, so individuals with cardiac conditions or heart valve problems should be cautious. Microdosing may also not be suitable for people with a history of psychosis or a family history of psychosis.

It is recommended to start with a lower frequency of microdosing mushrooms and gradually increase the frequency over time as one becomes more familiar with the effects. It is also important to listen to your body and adjust the frequency accordingly. Some individuals may find that microdosing mushrooms every few days works best for them, while others may prefer a more sporadic approach, such as once a week or less frequently.

Overall, the frequency of microdosing mushrooms can vary depending on individual needs and preferences. It is important to stay informed about the legal status of psilocybin mushrooms and to consult professional guidance when necessary.

The effects of microdosing

Microdosing is said to offer a range of mental and physical health benefits, but there is a lack of research to support these claims. Microdosing is typically done at lower doses and non-daily schedules, and the general idea is to consume a tiny dose that may offer mental perks without causing a "trip" or a psychedelic experience.

Some people who microdose mushrooms report improved mood, more energy, and enhanced focus. Other positive effects may include improved productivity, creativity, clear thinking, and cognitive enhancement. Some people also microdose to self-medicate for cluster headaches, depression, and anxiety.

However, it is important to note that the effects of microdosing can vary widely from person to person, and some people may have unwanted experiences. For example, some people have reported negative effects such as insomnia, increased anxiety and depression, poor mood, low energy, physical discomfort, poor focus, and cognitive impairment.

Additionally, there are safety concerns associated with microdosing. For instance, repeated microdosing of psilocybin may cause valvular heart disease, and it may not be suitable for people with a history of psychosis or cardiac conditions. It is also important to consider that most substances used in microdosing are illegal in many areas, which further complicates research efforts.

While microdosing may offer potential benefits, it is important to approach it with caution and be aware of the possible risks and side effects. More research is needed to fully understand the effects of microdosing mushrooms.

The safety and legality of microdosing

Microdosing is generally considered safe, but there is limited research on its effects, and it is not recommended for certain groups of people. While it is not possible to become physically or psychologically dependent on magic mushrooms, regular use can lead to a tolerance for the drug.

There is some research that suggests microdosing psychedelics can have therapeutic benefits, such as treating cluster headaches, depression, and anxiety. However, there is also research that suggests repeated microdosing of psilocybin can cause valvular heart disease, so people with cardiac conditions and heart valve problems should avoid it. Microdosing may also not be safe for people with a history of psychosis or a family history of psychosis. It is also not recommended for pregnant or lactating women.

Before microdosing, it is advised that individuals undergo a physical and mental health assessment to determine their risk for adverse psychiatric and cardiovascular events.

In terms of legality, microdosing psychedelics is illegal under federal law in the United States and Canada. Psilocybin is classified as a Schedule I substance under the Controlled Substances Act (CSA), meaning it is illegal to possess, obtain, or produce. However, some states and cities in the US have decriminalized psilocybin, which means there are no criminal penalties for personal use, and enforcement is a low priority for law enforcement. Similarly, in Canada, there are pathways for individuals to legally access psilocybin for therapeutic purposes, such as through clinical trials and the Special Access Program.

Frequently asked questions